Navigation Links
TetraQ and Q-Pharm form strategic alliance
Date:6/16/2008

TetraQ, the integrated preclinical contract research provider based at The University of Queensland, and Q-Pharm, a leading early phase clinical trial facility in Australasia, have formed a strategic alliance.

The alliance aims to enhance the delivery of bioanalytical services to clients in the biotechnology and pharmaceutical industries.

It is considered to be a positive development for the two businesses, which are both commercialisation enterprises of the University to give industry access to UQ's cutting-edge research resources and expertise.

TetraQ is a leading contract research organization that offers a broad range of preclinical services to the biopharmaceutical industry. A component of TetraQ's services includes bioanalytical services supporting clinical studies (including bioavailability/ bioequivalence and drug-drug interaction studies).

Q-Pharm is a Phase 1 clinical trial provider, servicing the early phase trial requirements of the pharmaceutical and biotech industries in Australia and around the world.

According to Q-Pharm CEO, Professor Wayne Hooper, the alignment of the two organisations at the interface of the preclinical and early phase clinical stages of the drug development pathway presented significant opportunities for capturing operational economies, co-marketing of services and cross-referral of potential clients.

"Since 2002, Q-Pharm has been one of Australia's foremost providers of bioanalytical services in support of clinical studies. When we decided to outsource our bioanalytical services to TetraQ the synergistic possibilities became more apparent," Professor Hooper said.

"We can expand our range of services to existing and future clients with TetraQ's involvement. It's a very positive step forward for both businesses as well as our clients."

TetraQ's Executive Director, Professor Maree Smith, also said there were advantages in a strategic alliance.


'/>"/>
Contact: Rose-Marie Pennisi
61-733-467-374
Research Australia
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. TetraQ recognized for toxicology services
2. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
3. Martopia(R) Forms Strategic Alliance With Modern Healthcare Magazine
4. LehmanMillet Continues Expansion with Strategic Hires
5. Stille and Enova Form Strategic Partnership to Introduce Worlds Brightest LED Cordless Surgical Headlights Into Europe and Japan
6. Benjamin England, Former FDA Regulatory Counsel, to Testify on FDA Import Strategic Plan Before House Appropriations Subcommittee
7. Diet.com Enters Strategic Collaboration To Support Microsoft HealthVault
8. Lumenis Ltd. Announces Senior Leadership Appointments Strengthening the Companys Strategic Businesses
9. Avantium and BP Extend Strategic Partnership
10. 40 86 Strategic Income Fund Declares Dividend
11. Medco, LabCorp Strike Strategic Agreement for Research on Personalized Medicine and Pharmacogenomics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 22, 2015 Autocarinsurancebest.com has released a new ... commercial auto insurance policy . , Auto insurance quotes ... It is no longer necessary to call an agent or ... available online on a single website: http://autocarinsurancebest.com/ . , ...
(Date:1/22/2015)... NJ (PRWEB) January 22, 2015 Joan ... and keynote speaker at the upcoming 32nd Annual ... ACCME-accredited Physicians’ Education Resource®, LLC (PER®) , shares ... would have gone undetected if she had not followed ...
(Date:1/22/2015)... Recently, Weddingshe.com has added many trendy Champagne wedding ... revenues in the past three years. Today, the business announces ... According to the sales manager of the company, this is ... 2015. This point can be reflected on the discounted wedding ...
(Date:1/22/2015)... Payday lending practices in four southern states ... distress to the states that permit them, according to ... on Race and Wealth. , While they generate hundreds ... at the same time substantially depress economic activity, according ...
(Date:1/22/2015)... January 22, 2015 JJsHouse.com is a famous ... Today, the business announces its latest collection of wedding ... “The most important issue is the wedding dress on your ... in a woman’s life. Every bride wants to find the ...
Breaking Medicine News(10 mins):Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2
... have discovered a key molecule needed to kill the blood ... institute,s Molecular Genetics of Cancer and Cancer and Haematology divisions ... to work the death- inducing molecule Bim is required. The ... on a two- or three-pronged attack on both the tumour ...
... researchers participated in more than 50 studies on improvements ... be presented at the 2011 Annual Meeting of the ... from June 3 through 7. Research highlights include: ... tumor response, adverse events and surgical complications in patients ...
... By Amanda Gardner HealthDay Reporter , SATURDAY, June ... common cancer drug, Avastin, may benefit both early stage ovarian ... In both studies, presented Saturday at the annual meeting of ... was added to standard chemotherapy. But the high ...
... the University of North Carolina at Chapel Hill School ... transplantation of adult stem cells enriched with a bone-regenerating ... not healing properly. The UNC study team led ... biomedical engineering, demonstrated that stem cells manufactured with the ...
... people with knee injuries could benefit from a new type ... The world,s first clinical trial for the treatment of patients ... regulatory agency, the MHRA1, to commence. The current ... the meniscus, a procedure that often results in the early ...
... indicates that longer time to beginning adjuvant chemotherapy after surgery ... a study in the June 8 issue of JAMA ... published early online to coincide with its presentation at the ... cancer (CRC) is the third leading cause of cancer mortality ...
Cached Medicine News:Health News:New strategy to attack tumor-feeding blood vessels 2Health News:City of Hope researchers to present rectal cancer, palliative care, benchmarking studies at ASCO 2Health News:City of Hope researchers to present rectal cancer, palliative care, benchmarking studies at ASCO 3Health News:Cancer Drug Avastin Makes Inroads Against Ovarian Tumors 2Health News:Cancer Drug Avastin Makes Inroads Against Ovarian Tumors 3Health News:Stem cell treatment may offer option for broken bones that don't heal 2Health News:Pioneering stem cell bandage receives approval for clinical trial 2Health News:Following colorectal cancer surgery, longer delay before chemotherapy associated with worse survival 2
(Date:1/23/2015)... 23, 2015  Today the U.S. Food and Drug Administration ... prevention of serogroup B meningococcal disease in ... Trumenba®, which received FDA approval in October, represent a ... "I have heard over and over ...
(Date:1/23/2015)... 23, 2015 Research and Markets ( http://www.researchandmarkets.com/research/5dh22x/urinary_catheters ... Catheters Market (Indwelling or Foley Catheters, Intermittent Catheters and ... Size, Share, Growth, Trends and Forecast 2014 - 2020" ... At present, the global market for urinary catheters is ...
(Date:1/23/2015)... Md. , Jan. 23, 2015  Northwest Biotherapeutics, Inc. (NASDAQ: ... DCVax® personalized immune therapies for operable and inoperable solid tumor ... present at the 7 th Annual Phacilitate Immunotherapy Forum ... Bio,s presentation at Phacilitate will take place on January 26 ...
Breaking Medicine Technology:The National Meningitis Association (NMA) Applauds FDA Approval of Second Vaccine To Protect Against Serogroup B Meningococcal Disease 2Urinary Catheters Market (Indwelling or Foley Catheters, Intermittent Catheters and Male External or Condom Catheters) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Urinary Catheters Market (Indwelling or Foley Catheters, Intermittent Catheters and Male External or Condom Catheters) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 2NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 3
... Nov. 9, 2011 Reportlinker.com announces ... is available in its catalogue: ... in Europe - Reference Pricing and ... Drugs Pose Significant Challenge to Pharmaceutical ...
... Company (NYSE: KV.A/ KV.B) (the "Company" or "K-V"), today reported ... Food & Drug Administration ("FDA") approved product indicated to reduce ... who have a history of a singleton spontaneous preterm birth. ... 2011. From its launch date through October 31, 2011: ...
Cached Medicine Technology:Pharmaceutical Pricing and Reimbursement in Europe - Reference Pricing and Similar Initiatives Being Applied to Innovative Drugs Pose Significant Challenge to Pharmaceutical Companies 2Pharmaceutical Pricing and Reimbursement in Europe - Reference Pricing and Similar Initiatives Being Applied to Innovative Drugs Pose Significant Challenge to Pharmaceutical Companies 3Pharmaceutical Pricing and Reimbursement in Europe - Reference Pricing and Similar Initiatives Being Applied to Innovative Drugs Pose Significant Challenge to Pharmaceutical Companies 4Pharmaceutical Pricing and Reimbursement in Europe - Reference Pricing and Similar Initiatives Being Applied to Innovative Drugs Pose Significant Challenge to Pharmaceutical Companies 5Pharmaceutical Pricing and Reimbursement in Europe - Reference Pricing and Similar Initiatives Being Applied to Innovative Drugs Pose Significant Challenge to Pharmaceutical Companies 6Pharmaceutical Pricing and Reimbursement in Europe - Reference Pricing and Similar Initiatives Being Applied to Innovative Drugs Pose Significant Challenge to Pharmaceutical Companies 7K-V Pharmaceutical Announces Updated Makena® Performance Metrics 2K-V Pharmaceutical Announces Updated Makena® Performance Metrics 3K-V Pharmaceutical Announces Updated Makena® Performance Metrics 4K-V Pharmaceutical Announces Updated Makena® Performance Metrics 5K-V Pharmaceutical Announces Updated Makena® Performance Metrics 6K-V Pharmaceutical Announces Updated Makena® Performance Metrics 7K-V Pharmaceutical Announces Updated Makena® Performance Metrics 8
... the Antigen-Antibody Pens-Using a proprietary and patented ... fountain pens, called Antigen-Antibody pens-TM, that will ... blotting membranes in any form or shape ... dyes helps to see antigen being written ...
... Advantages of using the Antigen-Antibody Pens-Using ... designed and developed specialized fountain pens, called ... deliver or write/mark the blotting membranes in ... specially formulated antigen-bonded colored dyes helps to ...
... Liters of pure water, Complete, Compact Systems ... Water,Millipores compact S.D.S. Storage and Distribution Systems ... liters of purified water produced by Elix ... purity of stored water, provide effective protection ...
... 200 to 350 Liters of pure water, ... Distribution of Purified Water,Millipores compact S.D.S. Storage ... 200 to 350 liters of purified water ... to maintain consistent purity of stored water, ...
Medicine Products: